25 2) L'apparition d'herpès, p.27 ,
[Management of side effects of targeted therapies in renal cancer: stomatological side effects (mucositis, epistaxis)], Bull Cancer ,
Evaluation of everolimus in renal cell cancer, Expert Opinion on Pharmacotherapy, vol.28, issue.5, p.122940, 2013. ,
DOI : 10.1164/rccm.200911-1720OC
Oral and neurocutaneous phenotypes of familial tuberous sclerosis, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.111, issue.1, p.8794, 2011. ,
DOI : 10.1016/j.tripleo.2010.07.002
Tuberous sclerosis complex diagnosed from oral lesions, Sao Paulo Medical Journal, vol.131, issue.5, p.3515, 2013. ,
DOI : 10.1590/1516-3180.2013.1315441
The pathogenesis and imaging of the tuberous sclerosis complex, Pediatric Radiology, vol.13, issue.9, p.93652, 2008. ,
DOI : 10.1007/s00247-008-0832-y
Radiation-induced mucositis of the aerodigestive tract: prevention and treatment. MASCC/ISOO mucositis group's recommendations], Bull Cancer, vol.93, issue.2, p.20111, 2006. ,
Les thérapies ciblées inhibitrices de mTOR [Thèse d'exercice, 2013. ,
Tuberous sclerosis complex: everything old is new again, Journal of Neurodevelopmental Disorders, vol.105, issue.24, p.1419, 2009. ,
DOI : 10.1073/pnas.0712268105
Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions, Int J Clin Exp Pathol, vol.2, issue.3, p.24960, 2009. ,
Oral ulcers in kidney allograft recipients treated with sirolimus], Ann Dermatol Vénéréologie. nov, vol.135, issue.11, p.73741, 2008. ,
Tuberous Sclerosis, 1979. ,
DOI : 10.1016/B978-0-409-90018-7.50008-6
Tuberous sclerosis: A novel approach to diagnosis, Journal of Indian Society of Pedodontics and Preventive Dentistry, vol.29, issue.6, p.525, 2011. ,
DOI : 10.4103/0970-4388.90742
Disseminated herpes simplex virus type-1 infection in long-term usage of everolimus, The Journal of Dermatology, vol.35, issue.1, p.834, 2013. ,
DOI : 10.1111/j.1346-8138.2012.01674.x
Current Management of Tuberous Sclerosis Complex, Pediatric Drugs, vol.146, issue.9, p.299313, 2008. ,
DOI : 10.2165/00148581-200810050-00004
International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference, Pediatr Neurol. oct, vol.49, issue.4, p.25565, 2013. ,
Effets cutan??s des nouvelles mol??cules utilis??es en canc??rologie, La Revue de M??decine Interne, vol.30, issue.5, p.40110, 2009. ,
DOI : 10.1016/j.revmed.2009.02.001
Is mTOR inhibition a systemic treatment for tuberous sclerosis?, Italian Journal of Pediatrics, vol.39, issue.1, p.57, 2013. ,
DOI : 10.1038/sj.clpt.6100317
Rôle du papilloma virus humain (HPV) dans le développement des cancers des voies aéro-digestives supérieures (VADS) [Thèse d'exercice, 2011. ,
Tuberous sclerosis complex: genetics to pathogenesis, Pediatric Neurology, vol.29, issue.5, p.4049, 2003. ,
DOI : 10.1016/j.pediatrneurol.2003.09.002
Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol.116, issue.2, p.1106, 2013. ,
DOI : 10.1016/j.oooo.2013.02.022
International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference, Pediatr Neurol. oct, vol.49, issue.4, p.24354, 2013. ,
Clinical presentation and management of mTOR inhibitor-associated stomatitis, Oral Oncology, vol.47, issue.10, p.9981003, 2011. ,
DOI : 10.1016/j.oraloncology.2011.08.009
Cutaneous viral infections in organ transplant patients ,
Managing Stomatitis in Patients Treated With Mammalian Target of Rapamycin Inhibitors, Clinical Journal of Oncology Nursing, vol.15, issue.5, p.839, 2011. ,
DOI : 10.1188/11.CJON.E83-E89
Atlas des maladies de la muqueuse buccale, 1980. ,
Deciduous teeth in tuberous sclerosis, Clinical Genetics, vol.7, issue.1, p.3640, 1996. ,
DOI : 10.1111/j.1399-0004.1996.tb02343.x
Recognition of Tuberous Sclerosis in Adult Women: Delayed Presentation With Life-Threatening Consequences, Annals of Internal Medicine, vol.154, issue.12, p.806294, 2011. ,
DOI : 10.7326/0003-4819-154-12-201106210-00008
A biological approach to mucositis, J Support Oncol. févr, vol.2, issue.356, p.2132, 2004. ,
Oral and perioral lesions. The Practitioner, p.313, 1718. ,
Dermatologic and Dental Aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements, JAMA Dermatology, vol.150, issue.10, p.1095101, 2014. ,
DOI : 10.1001/jamadermatol.2014.938
Everolimus in renal cell carcinoma. Drugs Today Barc Spain, août, vol.46, issue.8, p.55766, 1998. ,
Oral complications of targeted cancer therapies: A narrative literature review, Oral Oncology, vol.47, issue.6, p.4418, 2011. ,
DOI : 10.1016/j.oraloncology.2011.03.028